-
Mashup Score: 28
Abstract. There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulation, distribution of cardiovascular (CV) risk fact
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
/PRNewswire/ — Ultromics’ EchoGo® Heart Failure, an AI solution for echocardiography with the potential to revolutionize the diagnosis of heart failure with…
Source: www.prnewswire.comCategories: Cardiologists, Latest HeadlinesTweet-
Ultromics announced its #AI-guided device for the diagnosis of #HFpEF via echo has received full marketing authorization from the #FDA This AI-guided device to detect HFpEF from a single #EchoFirst image, a diagnosis that is missed in up to 75% of cases https://t.co/7QEjekeajt
-
-
Mashup Score: 0
Ultromics announced its artificial intelligence-guided device for the diagnosis of HF with preserved ejection fraction via echocardiogram has received full marketing authorization from the FDA. The device (EchoGo Heart Failure) was developed by Ultromics, a spin-out of the University of Oxford, in collaboration with Mayo Clinic, according to a press release issued by the company.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: Ultromics announced its AI-guided device for the diagnosis of #HFpEF via echocardiogram has received full marketing authorization from the FDA @US_FDA @FDADeviceInfo #Cardiotwitter https://t.co/573aHMi6w6
-
-
Mashup Score: 0
Ultromics announced its artificial intelligence-guided device for the diagnosis of HF with preserved ejection fraction via echocardiogram has received full marketing authorization from the FDA. The device (EchoGo Heart Failure) was developed by Ultromics, a spin-out of the University of Oxford, in collaboration with Mayo Clinic, according to a press release issued by the company.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: Ultromics announced its AI-guided device for the diagnosis of #HFpEF via echocardiogram has received full marketing authorization from the FDA @US_FDA @FDADeviceInfo #Cardiotwitter https://t.co/573aHMi6w6
-
-
Mashup Score: 0
Ultromics announced its artificial intelligence-guided device for the diagnosis of HF with preserved ejection fraction via echocardiogram has received full marketing authorization from the FDA. The device (EchoGo Heart Failure) was developed by Ultromics, a spin-out of the University of Oxford, in collaboration with Mayo Clinic, according to a press release issued by the company.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Ultromics announced its AI-guided device for the diagnosis of #HFpEF via echocardiogram has received full marketing authorization from the FDA @US_FDA @FDADeviceInfo #Cardiotwitter https://t.co/573aHMi6w6
-
-
Mashup Score: 3Heart Failure & SGLT2is: The New Pillar in Care - 3 year(s) ago
Heart Failure & SGLT2is: The New Pillar in Care What You Will Learn Current heart failure patient management challenges How to distinguish pathophysiologic characteristics of HF Guideline-directed…
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A 74 y/o 👴 w/ #HFpEF (EF 60%), #hypertension, & #CKD on hemodialysis presents for 🏥 follow-up. He was recently admitted for #heartfailure. ❓ Your patient should not be considered for a #SGLT2i at this time. A. Fact B. Fiction Comment 👇 & learn more: https://t.co/BvqwdM2iHJ https://t.co/McDfvU9oPg
-
-
Mashup Score: 1Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction - 3 year(s) ago
Background The pathobiology of heart failure with preserved ejection fraction (HFpEF) is still poorly understood, and effective therapies remain limited. Diabetes and mineralocorticoid excess are c…
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
Type 2 diabetes and high aldosterone levels synergistically promote #HFpEF @BenHegyi #AHAJournals https://t.co/pJhKHLpENy https://t.co/Uk3Fvd8hzT
-
-
Mashup Score: 0
Background: Heart failure with preserved ejection fraction (HFpEF) is a growing health problem without effective therapies. Epidemiological studies indicate that diabetes is a strong risk factor for
Source: Circulation ResearchCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Wu & colleagues found that activation of the longevity gene #SIRT6 could mitigate #diabetes-associated #HeartFailure with preserved ejection fraction or #HFpEF. Learn more at https://t.co/j6QfQotAe6 https://t.co/wgNs1KIXll
-
-
Mashup Score: 7Home | delivertrial - 3 year(s) ago
The DELIVER trial was an international randomized trial comparing dapagliflozin to placebo in patients with heart failure with mildly reduced or preserved ejection fraction.
Source: delivertrialCategories: Cardiologists, Latest HeadlinesTweet-
Inspiring #BrighamCVGrandRounds today by @scottdsolomon Describing remarkable and hopeful journey of progress in #HFpEF drug development Closing with this last chapter from #DELIVER https://t.co/A6YqOQ0bhM ICYMI Recording soon to be available: https://t.co/CtS9I3U5HZ https://t.co/2GrYYn6QWd
-
-
Mashup Score: 8Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management - 3 year(s) ago
It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection fraction (HFpEF). Yet this form of HF remains a diagnostic and therapeutic challenge. Differentiating HFpEF from other causes of dyspnoea may require advanced diagnostic methods, such as exercise echocardiography, invasive haemodynamics and investigations for ‘HFpEF mimickers’. While the…
Source: HeartCategories: Cardiologists, Latest HeadlinesTweet-
Fantastic🧵 on diagnosing #HFpEF In addition to clinical tools, consider #stress #echofirst to uncover exercise-induced diastolic dysfunction with ⬆️LV filling pressures. Important especially in patients with exertional symptoms. #HF https://t.co/pkan1poK6C https://t.co/YPGEKAu6Cu
-
Females w HTN develop #AFib & #HFpEF, while men develop #AMI & #HFrEF more often CV risk⬆️at lower BP level in females than in males Would different diagnostic BP threshold values or treatment targets in females & males with hypertension improve CVD💀? https://t.co/XEHlAi5i5z https://t.co/SZHfDVvcHI